Robert Foronjy is a Respiratory physician affiliated with State University of New York. OpenAlex indexes 156 publications with 3,711 citations (h-index 36).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Clarkson Ave
Pulmonary And Critical Care Division
Brooklyn, NY 112032012
Telephone
718-270-1770Registry record last updated 26 May 2015.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ANI Pharmaceuticals, Inc.Program year202513 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20256 payments
- Actelion Pharmaceuticals US, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
85.6%Corticosteroid34.1%Trelegy Ellipta57%Breo Ellipta13%Budesonide-Formoterol Fumarate9%Fluticasone Propionate8%Breztri Aerosphere5%Symbicort3%Arnuity Ellipta2%Budesonide2%Part D<11 patientsbeta2-Adrenergic Agonist32.4%Albuterol Sulfate Hfa95%Ventolin Hfa5%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
7.3%Corticosteroid7.3%Prednisone100%Part D≥56 patientsAnti-infectives
4.3%Tetracycline-class Drug3.6%Doxycycline Monohydrate100%Part D≥33 patientsShort-acting sulfonamides0.7%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2010–2025 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lung Function in Women With and Without Human Immunodeficiency Virus
Clinical Infectious Diseases
2022 - Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary disease
American Journal of Physiology-Lung Cellular and Molecular Physiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Harold Lebovitz, MD
State University of New York
Samy McFarlane, MD
State University of New York
Joseph Franciosa, MD
State University of New York
Sheldon Landesman, MD
State University of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”